Curis to Present at 2022 Jefferies Global Healthcare Conference
LEXINGTON, Mass., June 2, 2022 /PRNewswire/ — Curis, Inc. (NASDAQ: CRIS), a biotechnology company focused on the development of innovative therapeutics for the treatment of cancer, today announced that James Dentzer, President and Chief Executive Officer of Curis, will present a company…
Comments Off on Curis to Present at 2022 Jefferies Global Healthcare Conference